| |
Recent News
April 15, 2012 :: |
CritiTech Founder,
Dr. Bala Subramaniam to present at International Symposium
on Supercritical Fluids in San Francisco, May 13-16. See
attached Abstract.
Jahna Howell, Director of Lab Operations at CritiTech,
to attend as well. |
|
April 13, 2012 :: |
Planting Saplings
in India - (click photos to enlarge)
|
|
April 10, 2012 :: |
CritiTech Collaborator,
Dr. Kim A. Selting presented a poster on CritiTech's CTI
52010 at the 2nd World Veterinary Cancer Congress in Paris.
Click
here to view PDF. |
|
March 19, 2012 :: |
CritiTech,
Inc. and Mechanical Systems Inc. (MSI), a premier mechanical
systems solutions provider for the pharmaceutical industry,
announce the formation of a strategic alliance. |
|
February 13, 2012 :: |
Dr. David Johnston,
CEO and Dr. Bala Subramaniam, Founder; Scientific Advisor,
will be in India the last week of March |
news archive |
|
|
|
|
CritiTech
CritiTech specializes in optimizing the delivery
of challenging drug substances-- potent molecules, poorly
soluble compounds and biomolecules. Using our proprietary
SCF Technology and our ability to simplify formulations we
can extend the potential delivery options to oral, injection,
inhalation routes as well as to implantable devices. We thus
provide the differentiated products that truly benefit patients
in all age groups from pediatric to geriatric. We develop
products with significant commercial potential both independently
and in collaboration with strategic partners.
Our New C-FPC-411 Crystallizer
Click here for more
|
|
|
Current Clinical Trials
Nanotax®
(Ovarian Cancer)
Quick Links
eNews
Downloads
Events
Video
Portal
Case Studies
CS
#106 (Fusion Inhibitor)
CS#107
(Natural Product)
>case
archive
|
|
